CLS Publishes Interim Report January – March 2026

▤ Summary

Constellation Software reported a 20% year-over-year revenue increase with continued organic growth of 6%, driven largely by acquisitions. The company completed roughly US$700 million in deals during the quarter and has committed about US$800 million in further acquisitions, signaling confidence in its M&A pipeline. Analysts and UBS argue investor fears about AI-driven disruption may be overdone, highlighting Constellation's strong free cash flow, disciplined capital allocation and absence of stock-based compensation. UBS views the recent valuation weakness as an opportunity given the company's execution and acquisition strategy in both private and public markets.

▦ Linked Companies

Clinical Laserthermia Systems AB (CLS)

$1M to $5M